Loading...
TIAM1 variants improve clinical outcome in neuroblastoma
Identification of tumor driver mutations is crucial for improving clinical outcome using a personalized approach to the treatment of cancer. Neuroblastoma is a tumor of the peripheral sympathetic nervous system for which only a few driver alterations have been described including MYCN amplification...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5542186/ https://ncbi.nlm.nih.gov/pubmed/28423360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16787 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|